Bernstein on Arrowhead Pharma (ARWR): 'Obesity Data Meets Our Solid Win Scenario'
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering reiterated a Market Perform rating and $35.00 price target on Arrowhead Pharma (NASDAQ: ARWR).The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
